Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Clostridium difficile infection? 1,419 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,419 reports of Clostridium difficile infection have been filed in association with INFLIXIMAB (Renflexis). This represents 1.0% of all adverse event reports for INFLIXIMAB.

1,419
Reports of Clostridium difficile infection with INFLIXIMAB
1.0%
of all INFLIXIMAB reports
27
Deaths
686
Hospitalizations

How Dangerous Is Clostridium difficile infection From INFLIXIMAB?

Of the 1,419 reports, 27 (1.9%) resulted in death, 686 (48.3%) required hospitalization, and 8 (0.6%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 1,419 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508) CYCLOPHOSPHAMIDE (504)

Which INFLIXIMAB Alternatives Have Lower Clostridium difficile infection Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection INFLIXIMAB Demographics